Sandeep Nagra
About
Sandeep Nagra is a scholar working on Hematology, Immunology and Oncology.
According to data from OpenAlex, Sandeep Nagra has authored 21 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Immunology and 5 papers in Oncology. Recurrent topics in Sandeep Nagra's work include Hematopoietic Stem Cell Transplantation (15 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Sandeep Nagra is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Sandeep Nagra collaborates with scholars based in United Kingdom, Croatia and Canada. Sandeep Nagra's co-authors include Charles Craddock, Ram Malladi, Paul Moss, Charlotte Inman, Nigel H. Russell, Jane Nunnick, Jenny Byrne, Janice Ward, Sridhar Chaganti and Joanne Croudace and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and European Journal of Immunology.
In The Last Decade
Sandeep Nagra
20 papers receiving 514 citations
Peers
Sandeep Nagra
Fábio R. Kerbauy Brazil
Sergey N. Bondarenko Russia
Meiqing Wu China
Albert Esquirol Spain
Radwan Massoud Lebanon
James Morton Australia
Cristina Skert Italy
Sinem Civriz Bozdağ Türkiye
Toshiro Kawakita Japan
Paola Carluccio Italy
Citations per year, relative to Sandeep Nagra Sandeep Nagra (= 1×)
peers
Fábio R. Kerbauy
Countries citing papers authored by Sandeep Nagra
Since
Specialization
Citations
This map shows the geographic impact of Sandeep Nagra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandeep Nagra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandeep Nagra more than expected).
Fields of papers citing papers by Sandeep Nagra
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sandeep Nagra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandeep Nagra. The network helps show where Sandeep Nagra may publish in the future.
Co-authorship network of co-authors of Sandeep Nagra
This figure shows the co-authorship network connecting the top 25 collaborators of Sandeep Nagra. A scholar is included among the top collaborators of Sandeep Nagra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandeep Nagra. Sandeep Nagra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pearce, Hayden, Charlotte Inman, Karen Piper Hanley, et al.. (2021). DNA and modified vaccinia Ankara prime–boost vaccination generates strong CD8+ T cell responses against minor histocompatibility antigen HA‐1. British Journal of Haematology. 195(3). 433–446.
2.
Kinsella, Francesca, Jianmin Zuo, Charlotte Inman, et al.. (2019). Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells. Blood Advances. 3(5). 734–743.
3.
Kinsella, Francesca, Charlotte Inman, Y L Tracey Chan, et al.. (2019). Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease. Leukemia Research. 83. 106173–106173.
4.
Craddock, Charles, Aimee Jackson, Ram Malladi, et al.. (2019). The Sequential Flamsa-Bu Conditioning Regimen Does Not Improve Outcome in Patients Allografted for High Risk Acute Myeloid and Myelodysplasia Irrespective of Pre-Transplant MRD Status: Results of the UK NCRI Figaro Trial. Blood. 134(Supplement_1). 2031–2031.
5.
Inman, Charlotte, Joanne Croudace, Archana Sharma‐Oates, et al.. (2018). Unique features and clinical importance of acute alloreactive immune responses. JCI Insight. 3(10).
6.
Chan, Y L Tracey, Jianmin Zuo, Charlotte Inman, et al.. (2017). NK cells produce high levels of IL‐10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. European Journal of Immunology. 48(2). 316–329.
7.
Green, Kile, Kim Pearce, Rob S. Sellar, et al.. (2017). Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts. Biology of Blood and Marrow Transplantation. 23(5). 805–812.
8.
L’Huillier, Arnaud G., Stephen Perusini, Alireza Eshaghi, et al.. (2017). Evaluation of Altona Diagnostics RealStar Zika Virus Reverse Transcription-PCR Test Kit for Zika Virus PCR Testing. Journal of Clinical Microbiology. 55(5). 1576–1584.
9.
Burns, David, Sohail Rana, Elizabeth Martin, et al.. (2016). Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT. Bone Marrow Transplantation. 51(6). 825–832.
10.
Craddock, Charles, Shamyla Siddique, Christina Yap, et al.. (2015). Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial. Biology of Blood and Marrow Transplantation. 22(2). 385–390.
11.
Burns, David, Claire Shannon‐Lowe, Charlotte Inman, et al.. (2015). Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event. Blood. 126(25). 2665–2675.
12.
Nikolousis, Emmanouil, Sandeep Nagra, Rachel Pearce, et al.. (2014). Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: A British Society of Blood and Marrow Transplantation study. Bone Marrow Transplantation. 50(1). 82–86.
13.
Kinsella, Francesca, Charlotte Inman, Sandeep Nagra, et al.. (2014). Split Mixed Donor Chimerism Early after T-Cell Depleted Reduced Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation Predicts Survival. Blood. 124(21). 423–423.
14.
Nagra, Sandeep, et al.. (2014). Transfusion of CMV Seronegative T-Deplete Allogeneic Stem Cell Transplant Recipients with CMV Unselected Blood Products Confers a Zero Risk of CMV Transmission in the Era of Universal Leucodepletion: A UK Single-Centre Experience. Blood. 124(21). 2894–2894.
15.
Nikolousis, Emmanouil, Stephen Robinson, Sandeep Nagra, et al.. (2013). Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant. Leukemia Research. 37(5). 561–565.
16.
Medd, Patrick, Sandeep Nagra, Daniel Hollyman, Charles Craddock, & Ram Malladi. (2012). Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival. Bone Marrow Transplantation. 48(2). 243–248.
17.
Watson, L., Sandeep Nagra, Mark Cook, et al.. (2011). Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation. Bone Marrow Transplantation. 47(4). 528–534.
18.
Protheroe, Rachel, Keiren Kirkland, Rachel M. Pearce, et al.. (2011). The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplantation. 47(1). 88–94.
19.
Arrazi, Julie, et al.. (2010). Prediction of Intravenous Cyclosporine Area Under the Concentration–Time Curve After Allogeneic Stem Cell Transplantation. Therapeutic Drug Monitoring. 32(3). 353–358.
20.
Nikolousis, Emmanouil, Sandeep Nagra, Shankara Paneesha, et al.. (2010). Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies. Annals of Hematology. 89(11). 1141–1145.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fábio R. Kerbauy Breakdown of academic impact, for papers by Sergey N. Bondarenko Breakdown of academic impact, for papers by Meiqing Wu Breakdown of academic impact, for papers by Albert Esquirol Breakdown of academic impact, for papers by Radwan Massoud Breakdown of academic impact, for papers by James Morton Breakdown of academic impact, for papers by Cristina Skert Breakdown of academic impact, for papers by Sinem Civriz Bozdağ Breakdown of academic impact, for papers by Toshiro Kawakita Breakdown of academic impact, for papers by Paola Carluccio